Rybelsus

Having met the MHRA’s rigorous standards of safety, quality and effectiveness, the Wegovy aka semaglutide tablet has been approved in the UK for weight loss and weight management....

Mounjaro (Tirzepatide) has been given the title of a life-changing drug, helping some people lose up to 20% of their body weight. But what if the scales have stopped moving for you? Weight loss slow or stalled? Keep reading... Not seeing results with weight loss medications can be frustrating and discouraging. It may seem like the medication isn't effective. However, you're not alone, and there's often a reason why your weight loss has plateaued. This article will explain why

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with Semaglutide, the well-known active ingredient within Ozempic, Rybelsus and Wegovy.

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with semaglutide (Ozempic, Rybelsus & Wegovy)

Maintaining weight loss can be more challenging than losing the weight itself. Many people find that after reaching their target weight, old habits creep back in, and the scale starts to climb again. The key to lasting weight management lies in a balanced approach that includes changes in diet, gradual increases in exercise, and, when applicable, thoughtful adjustments to medications like Mounjaro or Wegovy. This post explores practical methods to sustain weight loss by integ

Weight loss medications like Mounjaro and Wegovy have become popular tools for managing weight. These GLP-1 receptor agonists help reduce appetite and improve blood sugar control, supporting effective weight management. Yet, one challenge many face during weight loss is muscle loss, which can affect strength, metabolism, and overall health. Understanding how protein and a balanced diet play a role in preserving muscle mass during weight loss is essential for anyone using thes

The US Food and Drug Administration (FDA) has approved a tablet version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. Although Oral Semaglutide is already on the market in the UK as the brand Rybelsus, this is currently licensed for Type 2 Diabetes. However, Rybelsus can be prescribed off-label for weight loss within the UK by a qualified healthcare professional, which is helpful for those who do not like injections or have needle phobia. Thi